Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospital Medicine | 8 | 2025 | 33 | 2.740 |
Why?
|
| Medical Overuse | 8 | 2022 | 23 | 1.880 |
Why?
|
| Hospitals, Pediatric | 13 | 2025 | 800 | 1.830 |
Why?
|
| Bronchiolitis | 6 | 2019 | 126 | 1.610 |
Why?
|
| Pediatrics | 13 | 2025 | 1242 | 1.490 |
Why?
|
| Hospitalists | 5 | 2021 | 53 | 1.380 |
Why?
|
| Child, Hospitalized | 2 | 2019 | 76 | 1.040 |
Why?
|
| Guideline Adherence | 4 | 2025 | 387 | 0.950 |
Why?
|
| Patient Readmission | 3 | 2020 | 436 | 0.870 |
Why?
|
| Medicine | 2 | 2024 | 99 | 0.830 |
Why?
|
| Pneumonia | 2 | 2018 | 340 | 0.820 |
Why?
|
| Community-Acquired Infections | 2 | 2017 | 252 | 0.820 |
Why?
|
| Quality of Health Care | 3 | 2018 | 408 | 0.760 |
Why?
|
| Child Health | 2 | 2024 | 68 | 0.740 |
Why?
|
| Quality Improvement | 4 | 2019 | 708 | 0.700 |
Why?
|
| Child | 32 | 2025 | 26173 | 0.610 |
Why?
|
| Benchmarking | 2 | 2017 | 138 | 0.590 |
Why?
|
| Adolescent Health | 1 | 2019 | 17 | 0.580 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2018 | 50 | 0.560 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 198 | 0.550 |
Why?
|
| Forced Expiratory Volume | 1 | 2018 | 178 | 0.540 |
Why?
|
| Habits | 1 | 2018 | 27 | 0.540 |
Why?
|
| Practice Guidelines as Topic | 6 | 2025 | 1282 | 0.520 |
Why?
|
| Standard of Care | 1 | 2018 | 131 | 0.510 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 205 | 0.500 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2018 | 133 | 0.500 |
Why?
|
| Cannula | 1 | 2017 | 31 | 0.500 |
Why?
|
| Asthma | 3 | 2020 | 919 | 0.480 |
Why?
|
| Oximetry | 1 | 2017 | 176 | 0.480 |
Why?
|
| Patient Handoff | 1 | 2016 | 23 | 0.480 |
Why?
|
| Insurance, Health | 1 | 2016 | 142 | 0.460 |
Why?
|
| Hypoxia | 1 | 2017 | 247 | 0.460 |
Why?
|
| Oseltamivir | 2 | 2025 | 19 | 0.450 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 461 | 0.440 |
Why?
|
| Hospitalization | 6 | 2025 | 1935 | 0.440 |
Why?
|
| Pneumonia, Bacterial | 1 | 2015 | 78 | 0.430 |
Why?
|
| Humans | 51 | 2025 | 130071 | 0.420 |
Why?
|
| Patient Discharge | 1 | 2018 | 513 | 0.420 |
Why?
|
| Bacteremia | 2 | 2015 | 433 | 0.400 |
Why?
|
| Patient Safety | 1 | 2018 | 443 | 0.400 |
Why?
|
| Career Choice | 1 | 2015 | 167 | 0.390 |
Why?
|
| Disease Management | 1 | 2017 | 553 | 0.380 |
Why?
|
| Primary Health Care | 1 | 2019 | 766 | 0.380 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 641 | 0.370 |
Why?
|
| Diagnostic Errors | 2 | 2015 | 342 | 0.370 |
Why?
|
| Choice Behavior | 1 | 2013 | 140 | 0.360 |
Why?
|
| Medication Adherence | 1 | 2015 | 335 | 0.360 |
Why?
|
| Periodicals as Topic | 1 | 2014 | 182 | 0.350 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 968 | 0.340 |
Why?
|
| Caregivers | 2 | 2021 | 589 | 0.330 |
Why?
|
| Venous Thrombosis | 1 | 2012 | 164 | 0.320 |
Why?
|
| Antiviral Agents | 2 | 2025 | 801 | 0.300 |
Why?
|
| Osteomyelitis | 1 | 2012 | 208 | 0.300 |
Why?
|
| Leukocytosis | 1 | 2009 | 45 | 0.300 |
Why?
|
| Drug Eruptions | 1 | 2009 | 33 | 0.300 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2025 | 774 | 0.290 |
Why?
|
| Influenza, Human | 2 | 2025 | 703 | 0.290 |
Why?
|
| Allopurinol | 1 | 2009 | 79 | 0.280 |
Why?
|
| Child, Preschool | 12 | 2025 | 15004 | 0.280 |
Why?
|
| Gout Suppressants | 1 | 2009 | 75 | 0.280 |
Why?
|
| Eosinophilia | 1 | 2009 | 110 | 0.280 |
Why?
|
| Infant | 9 | 2021 | 13262 | 0.250 |
Why?
|
| Infant, Newborn | 8 | 2021 | 8547 | 0.240 |
Why?
|
| Adolescent | 12 | 2021 | 20800 | 0.240 |
Why?
|
| Length of Stay | 3 | 2020 | 1406 | 0.230 |
Why?
|
| HIV | 2 | 2003 | 173 | 0.220 |
Why?
|
| Receptors, CCR5 | 1 | 2003 | 30 | 0.190 |
Why?
|
| Fecal Impaction | 1 | 2022 | 9 | 0.190 |
Why?
|
| Lentivirus | 1 | 2002 | 80 | 0.190 |
Why?
|
| Point-of-Care Systems | 1 | 2025 | 213 | 0.180 |
Why?
|
| Ambulatory Care | 1 | 2025 | 400 | 0.180 |
Why?
|
| Gastroenteritis | 3 | 2019 | 306 | 0.180 |
Why?
|
| Health Services Misuse | 1 | 2022 | 23 | 0.180 |
Why?
|
| Sports Medicine | 1 | 2022 | 32 | 0.180 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2022 | 246 | 0.180 |
Why?
|
| Physical Examination | 2 | 2022 | 166 | 0.180 |
Why?
|
| Polypharmacy | 1 | 2021 | 36 | 0.170 |
Why?
|
| Female | 13 | 2025 | 70243 | 0.170 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 344 | 0.170 |
Why?
|
| Male | 13 | 2025 | 64375 | 0.170 |
Why?
|
| Hypertension | 1 | 2009 | 1349 | 0.170 |
Why?
|
| Metered Dose Inhalers | 1 | 2020 | 12 | 0.160 |
Why?
|
| Status Asthmaticus | 1 | 2020 | 23 | 0.160 |
Why?
|
| Radiography, Thoracic | 2 | 2018 | 145 | 0.160 |
Why?
|
| Magnesium | 1 | 2020 | 114 | 0.150 |
Why?
|
| Certification | 1 | 2020 | 67 | 0.150 |
Why?
|
| Blood Transfusion | 1 | 2022 | 292 | 0.150 |
Why?
|
| United States | 7 | 2025 | 11890 | 0.150 |
Why?
|
| Medically Unexplained Symptoms | 1 | 2019 | 11 | 0.150 |
Why?
|
| Medication Errors | 1 | 2021 | 192 | 0.150 |
Why?
|
| Administration, Intravenous | 1 | 2020 | 172 | 0.150 |
Why?
|
| Clinical Competence | 3 | 2020 | 1042 | 0.150 |
Why?
|
| Radiography | 2 | 2018 | 740 | 0.150 |
Why?
|
| Patient Care | 1 | 2020 | 98 | 0.150 |
Why?
|
| Laboratories, Hospital | 1 | 2019 | 24 | 0.150 |
Why?
|
| Electrolytes | 1 | 2019 | 59 | 0.150 |
Why?
|
| Literacy | 1 | 2019 | 14 | 0.150 |
Why?
|
| Genetic Vectors | 1 | 2002 | 892 | 0.150 |
Why?
|
| Unnecessary Procedures | 1 | 2019 | 61 | 0.140 |
Why?
|
| Respiratory Tract Diseases | 1 | 2019 | 80 | 0.140 |
Why?
|
| Rehydration Solutions | 1 | 2018 | 8 | 0.140 |
Why?
|
| Pregnancy in Adolescence | 1 | 2019 | 54 | 0.140 |
Why?
|
| Staff Development | 1 | 2018 | 50 | 0.140 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2019 | 141 | 0.140 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 130 | 0.130 |
Why?
|
| Curriculum | 2 | 2020 | 793 | 0.130 |
Why?
|
| Antimicrobial Stewardship | 1 | 2019 | 87 | 0.130 |
Why?
|
| Child Health Services | 1 | 2018 | 86 | 0.130 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 295 | 0.120 |
Why?
|
| Electrocardiography | 1 | 2022 | 972 | 0.120 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2017 | 88 | 0.120 |
Why?
|
| Lymphadenitis | 1 | 2015 | 26 | 0.120 |
Why?
|
| Retrospective Studies | 6 | 2020 | 17541 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2018 | 819 | 0.110 |
Why?
|
| Failure to Thrive | 1 | 2015 | 87 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1483 | 0.110 |
Why?
|
| Faculty, Medical | 1 | 2018 | 281 | 0.110 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2015 | 78 | 0.110 |
Why?
|
| Pedigree | 1 | 2018 | 1670 | 0.110 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 3776 | 0.110 |
Why?
|
| Aftercare | 1 | 2015 | 156 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2018 | 1439 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2022 | 903 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2019 | 12831 | 0.100 |
Why?
|
| Oxygen | 1 | 2017 | 549 | 0.100 |
Why?
|
| Personnel, Hospital | 1 | 2014 | 33 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 1212 | 0.100 |
Why?
|
| Pediatricians | 2 | 2025 | 76 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2014 | 259 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2014 | 361 | 0.090 |
Why?
|
| Physician's Role | 1 | 2014 | 164 | 0.090 |
Why?
|
| Steroids | 1 | 2012 | 169 | 0.090 |
Why?
|
| Evidence-Based Practice | 1 | 2012 | 115 | 0.090 |
Why?
|
| Fever | 2 | 2015 | 310 | 0.090 |
Why?
|
| Leadership | 1 | 2014 | 246 | 0.090 |
Why?
|
| Communication | 1 | 2015 | 538 | 0.080 |
Why?
|
| Bronchodilator Agents | 1 | 2012 | 156 | 0.080 |
Why?
|
| Urinary Tract Infections | 1 | 2015 | 336 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2019 | 5038 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2012 | 181 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2569 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 448 | 0.080 |
Why?
|
| Transaminases | 1 | 2009 | 37 | 0.080 |
Why?
|
| Methylprednisolone | 1 | 2009 | 94 | 0.070 |
Why?
|
| Disease Progression | 1 | 2015 | 2193 | 0.070 |
Why?
|
| Mutation | 1 | 2003 | 6070 | 0.070 |
Why?
|
| Societies, Medical | 1 | 2013 | 792 | 0.070 |
Why?
|
| Quality of Life | 1 | 2019 | 2069 | 0.070 |
Why?
|
| Cell Line | 2 | 2003 | 2553 | 0.070 |
Why?
|
| Critical Illness | 1 | 2012 | 623 | 0.070 |
Why?
|
| Hospitals, Community | 2 | 2020 | 51 | 0.070 |
Why?
|
| Fluid Therapy | 2 | 2018 | 140 | 0.070 |
Why?
|
| Time Factors | 1 | 2017 | 6169 | 0.060 |
Why?
|
| Comorbidity | 1 | 2012 | 1583 | 0.060 |
Why?
|
| Syndrome | 1 | 2009 | 1157 | 0.060 |
Why?
|
| Pregnancy | 1 | 2019 | 7392 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2016 | 1218 | 0.060 |
Why?
|
| Risk Factors | 3 | 2019 | 10950 | 0.060 |
Why?
|
| Surveys and Questionnaires | 2 | 2025 | 4032 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 1260 | 0.060 |
Why?
|
| Outpatients | 1 | 2025 | 262 | 0.050 |
Why?
|
| DNA Footprinting | 1 | 2003 | 12 | 0.050 |
Why?
|
| New York | 1 | 2022 | 69 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2003 | 150 | 0.050 |
Why?
|
| DNA Primers | 1 | 2003 | 600 | 0.040 |
Why?
|
| Dosage Forms | 1 | 2021 | 9 | 0.040 |
Why?
|
| Drug Storage | 1 | 2021 | 18 | 0.040 |
Why?
|
| Medication Reconciliation | 1 | 2021 | 17 | 0.040 |
Why?
|
| Pamphlets | 1 | 2021 | 21 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 217 | 0.040 |
Why?
|
| Communication Barriers | 1 | 2021 | 46 | 0.040 |
Why?
|
| Athletes | 1 | 2022 | 76 | 0.040 |
Why?
|
| Forecasting | 1 | 2002 | 349 | 0.040 |
Why?
|
| Nonprescription Drugs | 1 | 2021 | 56 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2003 | 732 | 0.040 |
Why?
|
| Pneumothorax | 1 | 2022 | 78 | 0.040 |
Why?
|
| Health Literacy | 1 | 2021 | 75 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2025 | 942 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2003 | 449 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2021 | 723 | 0.040 |
Why?
|
| Tonsillectomy | 1 | 2022 | 113 | 0.040 |
Why?
|
| Language | 1 | 2021 | 215 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2003 | 1060 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2022 | 268 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 1453 | 0.040 |
Why?
|
| Medicaid | 1 | 2022 | 251 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 2390 | 0.040 |
Why?
|
| Base Sequence | 1 | 2003 | 2729 | 0.040 |
Why?
|
| Health Personnel | 1 | 2024 | 536 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3463 | 0.030 |
Why?
|
| Ankle Injuries | 1 | 2018 | 31 | 0.030 |
Why?
|
| Models, Biological | 1 | 2003 | 1375 | 0.030 |
Why?
|
| Inpatients | 1 | 2022 | 557 | 0.030 |
Why?
|
| Education | 1 | 2018 | 112 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2002 | 711 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2020 | 319 | 0.030 |
Why?
|
| Patient Harm | 1 | 2017 | 7 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 2018 | 219 | 0.030 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2020 | 497 | 0.030 |
Why?
|
| Urography | 1 | 2015 | 19 | 0.030 |
Why?
|
| Mass Screening | 1 | 2022 | 817 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2015 | 56 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 319 | 0.030 |
Why?
|
| Education, Medical | 1 | 2018 | 290 | 0.030 |
Why?
|
| Parents | 1 | 2021 | 1117 | 0.030 |
Why?
|
| Interinstitutional Relations | 1 | 2012 | 20 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 320 | 0.020 |
Why?
|
| Physical Therapy Modalities | 1 | 2012 | 51 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2012 | 151 | 0.020 |
Why?
|
| Program Development | 1 | 2012 | 180 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 222 | 0.020 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 186 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2076 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2289 | 0.020 |
Why?
|
| Students, Medical | 1 | 2014 | 350 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 1152 | 0.020 |
Why?
|
| Depression | 1 | 2018 | 1311 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 6397 | 0.020 |
Why?
|
| Adult | 1 | 2025 | 31012 | 0.010 |
Why?
|
| Animals | 1 | 2002 | 33660 | 0.010 |
Why?
|